Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Procedure for crystallization of (22E)-(24R)-2-methylene-22-dehydro-1α,24-25-trihydroxy-19-nor-vitamin D3

Procedure for crystallization of (22E)-(24R)-2-methylene-22-dehydro-1α,24-25-trihydroxy-19-nor-vitamin D3

US Patent 11697635 · Granted Jul 11, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of homosalate and octyl salicylate to treat multiple sclerosis2022
Use of homosalate and octyl salicylate to treat multiple sclerosis2022
Method of treating multiple sclerosis2022
Methods for detecting 1,25-dihydroxyvitamin D and related antibodies2022
Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarke2021
Method for treating multiple sclerosis2020
Methods for detecting 1,25-dihydroxyvitamin D and related antibodies2019
(20S)-1-α,25-dihydroxy-24,24-difluoro-19-nor-vitamin D3 analogs and their pharma2019
(20S)-1-α,25-dihydroxy-24,24-difluoro-19-nor-vitamin D3 analogs and their pharma2019
(20S)-1-α,25-dihydroxy-24,24-difluoro-19-nor-vitamin D3 analogs and their pharma2019
(20S)-1-α,25-dihydroxy-24,24-difluoro-19-nor-vitamin D3 analogs and their pharma2019
(20S)-1-α,25-dihydroxy-24,24-difluoro-19-nor-vitamin D3 analogs and their pharma2019